Renge Bu
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Renal and related cancers
Papers in
-
- Epigenetics and DNA Methylation 4
- Renal and related cancers 3
- Cancer-related gene regulation 3
- Circular RNAs in diseases 2
-
- Cancer-related molecular mechanisms research 3
- MicroRNA in disease regulation 2
- Co-authors
- Yongsheng Song (5 shared papers)Xiang Fei (4 shared papers)Bo Yin (4 shared papers)Wenyan Zhao (2 shared papers)Bin Wu (2 shared papers)Ming Li (2 shared papers)Ying Wang (1 shared paper)Ming Sun (1 shared paper)
- Journals
- Oncology Reports (1 paper)Analytical Cellular Pathology (1 paper)Journal of Cellular Physiology (1 paper)Oncotarget (1 paper)Oxidative Medicine and Cellular Longevity (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Renge Bu
12 papers receiving 286 citations
Peers
Comparison fields: 5 of 53
- Cancer Research 148
- Molecular Biology 209
- Pulmonary and Respiratory Medicine 67
- Rheumatology 27
- Obstetrics and Gynecology 10
Countries citing papers authored by Renge Bu
This map shows the geographic impact of Renge Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renge Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renge Bu more than expected).
Fields of papers citing papers by Renge Bu
This network shows the impact of papers produced by Renge Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renge Bu. The network helps show where Renge Bu may publish in the future.
Co-authors
The 25 scholars most cited alongside Renge Bu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 63 | |
| 2 | 2018 | 55 | |
| 3 | 2017 | 34 | |
| 4 | 2010 | 27 | |
| 5 | 2020 | 26 | |
| 6 | 2014 | 18 | |
| 7 | Expression profiling and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in sporadic human renal cell carcinoma. | 2014 | 17 |
| 8 | 2012 | 16 | |
| 9 | 2020 | 13 | |
| 10 | 2020 | 11 | |
| 11 | 2019 | 8 | |
| 12 | 2020 | 4 |
About Renge Bu
Renge Bu is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Aquatic Science, having authored 12 papers that have together received 292 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Renal and related cancers (3 papers), Cancer-related gene regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), MicroRNA in disease regulation (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Circular RNAs in diseases (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Cancer Research (148 citations), Molecular Biology (209 citations), Pulmonary and Respiratory Medicine (67 citations), Rheumatology (27 citations) and Obstetrics and Gynecology (10 citations). Renge Bu has collaborated with scholars based in China and United States. Frequent co-authors include Yongsheng Song, Xiang Fei, Bo Yin, Wenyan Zhao, Bin Wu, Ming Li, Ying Wang, Ming Sun, Bin Wu and Zhaofu Chen. Their work appears in journals such as Oncology Reports, Analytical Cellular Pathology, Journal of Cellular Physiology, Oncotarget and Oxidative Medicine and Cellular Longevity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.